ADALIMUMAB
Drug timelines are a Plus or Pro feature.
190 regulatory and trial events tracked for ADALIMUMAB, covering 2006-08-15 to 2026-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]